Abstract:The T-cell receptor (TCR) repertoires exhibits distinct signatures associated with COVID-19 severity. However, the precise identification of vaccine-induced SARS-CoV-2-specific TCRs and T-cell immunity mechanisms are unknown. We developed a machine-learning model that can differentiate COVID-19 patients from healthy individuals based on TCR sequence features with an accuracy of 95.7%. Additionally, we identified SARS-CoV-2-specific T cells and TCR in HLA-A*02 vaccinated individuals by peptide stimulation. The SARS-CoV-2-specific T cells exhibited higher cytotoxicity and prolonged survival when targeting spike-pulsed cells in vitro or in vivo. The top-performing TCR was further tested for its affinity and cytotoxic effect against SARS-CoV-2-associated epitopes. Furthermore, single-cell RNA sequencing (scRNA-seq), immune repertoire sequencing (IR-seq) and flow cytometry were used to access vaccine-induced cellular immunity, which demonstrated that robust T cell responses (T cell activation, tissue-resident memory T cell (Trm) generation, and TCR clonal expansion) could be induced by intranasal vaccination. In summary, we identified the SARS-CoV-2-associated TCR repertoires profile, specific TCRs and T cell responses. This study provides a theoretical basis for developing effective immunization strategies.

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are to identify and understand the characteristics of SARS - CoV - 2 - specific T cells and their receptors (TCR), as well as the T - cell - immune mechanisms induced by vaccines. Specifically, the researchers focus on the following aspects: 1. **The relationship between T - cell - receptor (TCR) characteristics and the severity of COVID - 19**: - By analyzing the peripheral - blood - TCR profiles of patients at different infection stages (acute, transition, and convalescent), the researchers found that TCR profiles showed significant differences at different stages, and compared with the healthy control group, the TCR profiles of infected patients showed a higher frequency - cluster preference, indicating that the TCR diversity increased after SARS - CoV - 2 infection. 2. **Machine - learning - model prediction of COVID - 19 infection**: - A machine - learning model based on TCR - sequence characteristics was developed, which can distinguish COVID - 19 patients from healthy individuals with an accuracy of 95.7%. The high accuracy of this model makes early diagnosis and disease - condition assessment possible. 3. **Identification of SARS - CoV - 2 - specific T cells**: - Through the peptide - MHC - tetramer - staining technique, SARS - CoV - 2 peptides that can be recognized by HLA - A*02+ T cells were screened out, especially the SLSSTASAL peptide (XG2 peptide). The study found that the XG2 peptide can significantly enhance the activation of CD8+ T cells and cytokine expression, showing higher cytotoxicity and viability. 4. **T - cell - immune response induced by vaccines**: - Through an intranasal - immunization - mouse model, the pulmonary T - cell response after stimulation by the SLSSTASAL peptide was studied. The results showed that after vaccination, the proportions of total T cells, central - memory T cells (Tcm), effector - memory T cells (Tem), and tissue - resident - memory T cells (Trm) in lung tissues increased significantly, and these T cells showed the expression of high - activation genes and cytokine genes. 5. **Expansion of TCR clonotypes**: - After antigen exposure, the TCR clonotypes in the local tissues of the lungs expanded significantly, indicating that the Trm response of specific epitopes can provide long - term protection against SARS - CoV - 2 infection. In conclusion, this study not only reveals the characteristics of SARS - CoV - 2 - specific T cells and their receptors but also provides a theoretical basis for the development of effective immunization strategies.

Identification of SARS-CoV-2-specific T cell and its receptor

Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity

Single-cell RNA sequencing reveals<i>in vivo</i>signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’

Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’

T cell receptor repertoires in patients with COVID-19 reveal disease severity signatures

T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures

Single Cell and Immune Repertoire Profiling of COVID-19 Patients Reveal Novel Therapeutic Candidates

Investigation of Long-Term CD4+ T Cell Receptor Repertoire Changes Following SARS-CoV-2 Infection in Patients with Different Severities of Disease

Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection

Identification of TCR Repertoires in Asymptomatic COVID-19 Patients by Single-Cell T-cell Receptor Sequencing

CoV2-TCR: a web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes

Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis

Identification of COVID-19-Specific Immune Markers Using a Machine Learning Method

A T-Cell-Derived 3-Gene Signature Distinguishes SARS-CoV-2 from Common Respiratory Viruses

Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection

Association between COVID-19 Disease Severity and T Cell Receptor Repertoire

SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

The characteristics of TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients

Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stage

Discovering SARS-CoV-2 Neoepitopes and the Associated TCR-pMHC Recognition Mechanisms by Combining Single-Cell Sequencing, Deep Learning, and Molecular Dynamics Simulation Techniques